Navigation Links
Transgenomic Reports Fourth Quarter Financial Results
Date:3/10/2011

$  20,048

$  22,023COST OF GOODS SOLD2,716

3,127

10,284

10,418Gross profit

2,376

3,388

9,764

11,605OPERATING EXPENSES:Selling, general and administrative

3,309

2,397

10,933

10,319Research and development

354

714

2,305

3,182Restructuring charges

66

  —

138

  —3,729

3,111

13,376

13,501INCOME (LOSS) FROM OPERATIONS(1,353)

277

(3,612)

(1,896)OTHER INCOME:Interest income (expense)

(6)

1

(4)

15Other, net

632

7

632

3626

8

628

18INCOME (LOSS) BEFORE INCOME TAXES(727)

285

(2,984)

(1,878)INCOME TAX EXPENSE 40

156

150

42NET INCOME (LOSS)$
(767)

$  129

$  (3,134)

$  (1,920)BASIC AND DILUTED INCOME (LOSS) PER SHARE:From continuing operations

$
(0.02)

$
.00

$  (0.06)

$  (0.04)BASIC WEIGHTED AVERAGE SHARES OUTSTANDING49,289,672

49,189,672

49,243,839

49,189,672DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING49,289,672

49,217,942

49,243,839

49,189,672Transgenomic, Inc.Summary Financial ResultsUnaudited Condensed Consolidated Statements of Cash Flows(dollars in thousands)Year Ended December 31,20102009NET CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES$  (1,718)

$
,267NET CASH FLOWS USED IN INVESTING ACTIVITIES(6,226)

(377)NET CASH FLOWS PROVIDED BY FINANCING ACTIVITIES5,761

—EFFECT OF FOREIGN CUR
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Transgenomic Announces Closing of the Acquisition of Clinical Datas Diagnostic Business and the Closing of a $6 Million Financing
2. Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark
3. Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference
4. Transgenomic to Present at the Noble Financial Sixth Annual Equity Conference - ONTRACK 2010
5. Transgenomic Reports Fourth Quarter Financial Results
6. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
7. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
8. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
9. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
10. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
11. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  Decision Resources Group finds that ... patients currently treated with Biogen Idec,s oral ... flushing and/or gastrointestinal events while on the ... experiencing these side effects, signifying either their ... of such events. In the end, fewer ...
(Date:7/22/2014)... BETHLEHEM, Pa. , July 22, 2014  Eyeon ... novel dry eye treatment based on a charged hydrophilic ... CDMO.  The product has been shown to be safe ... Mark Mitchnick , MD, CEO states, "This first set ... go a long way to moving this technology into ...
(Date:7/22/2014)... 2014  A central New York ... Total Artificial Heart implant is home, discharged ... the Freedom® portable driver to wait for a ... retiree from a Syracuse architectural hardware company, suffered ... with medications, an implantable defibrillator and a pacemaker. ...
Breaking Medicine Technology:Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... 2011 Amarin Corporation plc (Nasdaq: AMRN ) today ... presenting at two investor conferences on March 2, 2011. ... scheduled to present at the CITI 2011 Global Healthcare Conference ... conference will be held at the Hilton New York City. ...
... Mass., Feb. 22, 2011 MedTrust Online (MedTrust) ... collaboration to involve clinicians in the earliest stages ... revolutionary QPDx™ multiplex immunoassay system. ... of over 10,000 cancer care professionals with early ...
Cached Medicine Technology:Amarin to Present at Two Upcoming Investor Conferences 2Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care 2Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care 3
(Date:7/22/2014)... Washington, DC (PRWEB) July 22, 2014 Ticket ... vs. Inter Milan tickets at Fedex Field in Landover, MD. ... Sates to be a fan of international soccer. After the success ... in Brazil, soccer fever is alive and well. One way that ... hunger for the sport is with the 2014 Guinness International Champions ...
(Date:7/22/2014)... 2014 The park is the heart ... Kendalltown Homeowners Association, Inc., made a recent investment ... with the purchase of playground equipment from American Parks ... beautiful Miami Florida, and is a 475-unit community that ... surrounding landscape has created a tropical paradise with lush ...
(Date:7/22/2014)... By Kathleen Doheny ... -- Removing the uterus with a minimally invasive procedure known ... now a new study pinpoints the likelihood more clearly. ... undetected uterine cancer at the time of the procedure, researchers ... age of 65. Surgeons performing a hysterectomy with morcellation ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 CarePoint Health is ... elected as the President of the medical staff at Bayonne ... will serve as President, as voted on by the physicians ... the medical staff in relation to the administration at Bayonne ... of physicians and to work to make the Medical Center ...
(Date:7/22/2014)... Latin America Drilling fluid and Completion fluid Market Report defines ... Latin America with analysis and forecast of revenue. The drilling ... to grow from around $0.93 billion in 2013 to $1.45 ... given period. , Browse through the TOC of the Latin ... an idea of the in-depth analysis provided. This also provides ...
Breaking Medicine News(10 mins):Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 3Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6
... smoking raise Alzheimer,s risk , TUESDAY, Aug. 4 ... your heart in the middle years of life -- ... are bad for your brain in later years, new ... associated with an increased risk of Alzheimer,s disease and ...
... Effort aims to create an international Network of ... co-operative and collaborative approach to combating the problem of health ... Aug. 4 The National Health Care Anti-Fraud Association (NHCAA) ... with two like-minded organizations--the Canadian Health Care Anti-fraud Association (CHCAA) ...
... 4 CryoLife, Inc., (NYSE: CRY ) ... company, today announced it has received CE mark approval ... allows immediate, unrestricted commercial distribution of BioFoam in the ... sealing of abdominal parenchymal tissues (liver and spleen) when ...
... , , , ... SPL, OTCQX: SPHRY) today announced the results of its clinical ... virus (HIV) and herpes simplex virus (HSV, the virus that ... , The clinical study was conducted to assess ...
... , LOS ANGELES and RADNOR, Pa. ... Los Angeles-based private equity firm managing more than $2.0 billion in ... transactions to combine RecoverCare, LLC, and MedaSTAT USA, LLC, both privately ... , , The combined company, to be called ...
... , , INDIANAPOLIS, Aug. 4 ... provides innovative consumer health care services under the trade name Arcadia ... the opening of the U.S. financial markets on Thursday, August 13, ... conference call and simultaneous Internet webcast to review these financial results ...
Cached Medicine News:Health News:Midlife Heart Risk Factors Linked to Later Dementia 2Health News:Midlife Heart Risk Factors Linked to Later Dementia 3Health News:The National Health Care Anti-Fraud Association Signs Memorandum of Understanding With Canadian and European Anti-Fraud Organizations 2Health News:The National Health Care Anti-Fraud Association Signs Memorandum of Understanding With Canadian and European Anti-Fraud Organizations 3Health News:CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology 2Health News:CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology 3Health News:CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology 4Health News:VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration 2Health News:RecoverCare and MedaSTAT USA Complete Transaction 2Health News:RecoverCare and MedaSTAT USA Complete Transaction 3Health News:Arcadia Resources Announces Webcast of Its Fiscal 2010 First Quarter Conference Call 2
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
... An in vitro Nucleic Acid ... using Microplate Chemiluminescence for the ... (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 ... Lowand High-Risk Groups in Cervical ...
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
... AS100 Analyzer is designed ... regardless of the sample ... launched in December 2004, ... in May 2005. Assays ...
Medicine Products: